Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
The latest update is out from Mineralys Therapeutics, Inc. (MLYS).
Alexander Asam, Ph.D., has announced he will step down from the Board of Directors at Mineralys Therapeutics, Inc. upon the expiration of his term, coinciding with the 2024 annual stockholders’ meeting. Asam’s departure is not due to any conflicts with the company’s operations, policies, or practices, ensuring a drama-free transition for investors following the company’s governance.
For an in-depth examination of MLYS stock, go to TipRanks’ Stock Analysis page.
